The CUL3-KLHL18 ligase regulates mitotic entry and
ubiquitylates Aurora-A by Moghe, Saili et al.
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
Ronald Cerny Publications Published Research - Department of Chemistry
2011
The CUL3-KLHL18 ligase regulates mitotic entry
and ubiquitylates Aurora-A
Saili Moghe
University of Nebraska Medical Center, moghes1@unk.edu
Fei Jiang
University of Nebraska Medical Center
Yoshie Miura
University of Nebraska Medical Center
Ronald Cerny
University of Nebraska-Lincoln, rcerny1@unl.edu
Ming -Ying Tsai
University of Nebraska Medical Center
See next page for additional authors
Follow this and additional works at: http://digitalcommons.unl.edu/chemistrycerny
This Article is brought to you for free and open access by the Published Research - Department of Chemistry at DigitalCommons@University of
Nebraska - Lincoln. It has been accepted for inclusion in Ronald Cerny Publications by an authorized administrator of DigitalCommons@University of
Nebraska - Lincoln.
Moghe, Saili; Jiang, Fei; Miura, Yoshie; Cerny, Ronald; Tsai, Ming -Ying; and Furukawa, Manabu, "The CUL3-KLHL18 ligase
regulates mitotic entry and ubiquitylates Aurora-A" (2011). Ronald Cerny Publications. 10.
http://digitalcommons.unl.edu/chemistrycerny/10
Authors
Saili Moghe, Fei Jiang, Yoshie Miura, Ronald Cerny, Ming -Ying Tsai, and Manabu Furukawa
This article is available at DigitalCommons@University of Nebraska - Lincoln: http://digitalcommons.unl.edu/chemistrycerny/10
The CUL3-KLHL18 ligase regulates mitotic entry and
ubiquitylates Aurora-A
Saili Moghe1, Fei Jiang1, Yoshie Miura1,3, Ronald L. Cerny2, Ming-Ying Tsai1 and Manabu Furukawa1,*
1Eppley Institute for Research in Cancer and Allied Diseases, 987696 Nebraska Medical Center, University of Nebraska Medical Center, Omaha, NE
68198-7696, USA
2University of Nebraska, Lincoln, Nebraska 68588, USA. 3Present address. Division of Molecular and Clinical Genetics, Department of Molecular
Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan
*Author for correspondence (mfurukawa@unmc.edu)
Biology Open 1, 82–91
doi: 10.1242/bio.2011018
Summary
The cullin-RING family of ubiquitin ligases regulates diverse
cellular functions, such as cell cycle control, via ubiquitylation
of specific substrates. CUL3 targets its substrates through BTB
proteins. Here we show that depletion of CUL3 and the BTB
protein KLHL18 causes a delay in mitotic entry. Centrosomal
activation of Aurora-A, a kinase whose activity is required for
entry into mitosis, is also delayed in depleted cells. Moreover,
we identify Aurora-A as a KLHL18-interacting partner.
Overexpression of KLHL18 and CUL3 promotes Aurora-A
ubiquitylation in vivo, and the CUL3-KLHL18-ROC1 ligase
ubiquitylates Aurora-A in vitro. Our study reveals that the
CUL3-KLHL18 ligase is required for timely entry into mitosis,
as well as for the activation of Aurora-A at centrosomes. We
propose that the CUL3-KLHL18 ligase regulates mitotic entry
through an Aurora-A-dependent pathway.
 2011. Published by The Company of Biologists Ltd. This is
an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial Share Alike
License (http://creativecommons.org/licenses/by-nc-sa/3.0).
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Introduction
The regulation of mitotic progression relies predominantly on
two post-translational mechanisms: protein phosphorylation and
ubiquitylation. Ubiquitylation requires the sequential activities of
three enzymes: E1 (ubiquitin activating), E2 (ubiquitin
conjugating) and E3 (ubiquitin ligase) enzymes. E3 ligases
regulate ubiquitylation through the specific binding of a substrate
to an E2 (Hershko and Ciechanover, 1998). Since E3 ligases
specifically interact with a substrate protein and catalyze
ubiquitylation of the substrate, E3 ligases are primarily a
regulatory factor for the ubiquitin signaling pathway. The
cullin-RING ligases (CRLs) are the largest family of E3 ligases
(Petroski and Deshaies, 2005). CRLs consist of a cullin scaffold
protein, a small RING finger catalytic subunit ROC1 or ROC2
(also known Rbx1 or Rbx2), substrate targeting molecules such
as SKP1 and the F-box protein, and regulatory molecules such as
Nedd8, CAND1 and COP9 signalosome (Petroski and Deshaies,
2005). The human genome encodes eight cullin proteins (CUL1,
2, 3, 4A, 4B and 5, 7 and PARC/CUL9). All cullin scaffolds
interact with the ROC protein to recruit the E2, and each cullin
brings its unique substrate targeting machinery to ubiquitylate a
large number of specific substrates. Therefore CRLs are thought
to regulate many diverse cellular processes, yet most of their
substrates and functions are still unknown (Petroski and
Deshaies, 2005).
CUL3 targets its substrates through Bric-a-brac-Tramtrack-
Broad complex (BTB) domain containing proteins (BTB
proteins) (Furukawa et al., 2003; Geyer et al., 2003; Pintard et
al., 2003; Xu et al., 2003; Kobayashi et al., 2004; Furukawa and
Xiong, 2005). In humans, there are over 300 BTB proteins, each
potentially targets a specific substrate for ubiquitylation, yet only
a small number of CUL3-BTB protein ligases and their substrates
have been identified. Related to cell cycle control, it has been
shown that the CUL3-KLHL9/KLHL13, and CUL3-KLHL21
ligases ubiquitylate Aurora-B to control mitotic progression and
cytokinesis (Sumara et al., 2007; Maerki et al., 2009), the CUL3-
KLHDC5 ligase ubiquitylates p60Katanin for its degradation to
regulate microtubules (Cummings et al., 2009), and Cyclin E has
been proposed to be ubiquitylated for its degradation in a CUL3-
dependent manner (Singer et al., 1999; McEvoy et al., 2007).
Entry and progression of mitosis is tightly regulated by
multiple kinases including Aurora-A (Marumoto et al., 2005).
Mitotic entry is controlled by the activation of cyclin-dependent
kinase 1 (Cdk1), whose activity is regulated directly by mitotic
cyclins and phosphatase Cdc25, (Murray, 2004) and indirectly by
polo-like kinase 1 (Plk1) (Hansen et al., 2004; Lenart et al.,
2007). Plk1, Cdc25, and Cdk1 form a feedback loop and
positively regulate each other’s activity (Murray, 2004). Aurora-
A localizes at the centrosome and activates Plk1 with Bora,
leading to the activation of Cdk1 and in turn mitotic entry (Hirota
et al., 2003; Macurek et al., 2008; Seki et al., 2008). After
initiation of mitosis, Aurora-A accumulates at spindle poles and
the mitotic spindle to regulate the mitotic spindle through the
phosphorylation of spindle assembly factors (Marumoto et al.,
2005).
Here we show that depletion of CUL3 or a BTB protein,
KLHL18, causes a delay in mitotic entry and delayed activation
of Aurora-A at the centrosome. CUL3 and KLHL18 interact with
Aurora-A, and KLHL18 directly binds to Aurora-A. CUL3 and
KLHL18 promote Aurora-A ubiquitylation in vivo and the
82 Research Article
B
io
lo
g
y
O
p
e
n
CUL3-KLHL18-ROC1 complex is sufficient to ubiquitylate
Aurora-A in vitro. We propose that the CUL3-KLHL18 ligase
regulates mitotic entry through Aurora-A ubiquitylation that
leads to Aurora-A activation at the centrosome, and the initiation
of mitotic entry.
Results
CUL3 functions in mitotic entry
To examine possible cell cycle functions of CUL3 in human
cultured cells, we analyzed cell cycle distribution of CUL3
knockdown cells by flow cytometry. The accumulation of cells
with 4N DNA content was observed in both HeLa and U2OS
cells after knockdown of CUL3 by small interfering RNA
(siRNA) transfection, suggesting that CUL3 has mitotic functions
(Fig. 1A). We also observed increased number of multinucleated
cells and mitotic progression delay in CUL3 depleted cells
compared to control cells (data not shown, Fig. 1C) suggesting
CUL3 has functions in mitotic progression and cytokinesis,
consistent with previous reports (Sumara et al., 2007; Maerki et
al., 2009). In addition to the mitotic progression delay and the
cytokinesis defect, an accumulation of cells with 4N DNA can
also be caused by a delay or defect in mitotic entry. To determine
whether CUL3 is involved in mitotic entry, we combined cell
synchronization with RNA interference (RNAi). U2OS cells were
transfected with siRNAs in the interval between two thymidine
blocks and examined after release from the second thymidine
block (Fig. 2A). CUL3 protein was almost completely depleted at
the release from the 2nd thymidine block (Fig. 2C) and the
number of mitotic cells was decreased in CUL3 depleted cells as
compared to control cells at 8 hours after release (Fig. 2B). This
result indicates that depletion of CUL3 may delay mitotic entry.
To further confirm the function of CUL3 in mitotic entry, we
monitored the mitotic index of control and CUL3 depleted cells
Fig. 1. CUL3 functions in mitotic progression. (A) Asynchronous HeLa and U2OS cells were transfected with indicated siRNAs. 72 hours after transfection, cell
cycle profile was analyzed by flow cytometry, and (B) cell lysate was analyzed by western blotting (WB) with anti-CUL3 or anti-GAPDH (control). (C) Histone H2B-
GFP stably expressing HeLa cells were transfected with either control or CUL3 siRNAs. 48h after transfection, cells were analyzed by time-lapse antibodies
fluorescence microscopy. One representative cell for control and CUL3 RNAi is shown from chromosome condensation (0 min). Scale bars, 10 mm.
Fig. 2. CUL3 functions in mitotic entry. (A) A schematic protocol for cell
synchronization (by double thymidine block) and RNAi. (B, C, D) U2OS cells
were synchronized and transfected as indicated and subjected to the protocol
shown in (A) with indicated siRNAs. (B) Phase pictures of indicated siRNA
transfected cells at 8 hours after release. Scale bars, 100 mm. (C) When released
from 2nd thymidine block, cells were lysed and subjected to WB with indicated
antibodies. (D) Cells were fixed and stained with DAPI at the indicated times
after release. Over 500 cells were analyzed and mitotic index was determined.
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after release from double thymidine block (Fig. 2D). Mitotic
entry was significantly delayed in CUL3 depleted cells compared
to control cells. These results suggest that CUL3 may regulate
mitotic entry.
CUL3 localizes at centrosomes and the mitotic spindle
To understand the early mitotic function of CUL3, we determined
endogenous CUL3 localization during mitosis in human cultured
cells by indirect immunofluorescence microscopy (Fig. 3A).
CUL3 localized predominantly in the nucleus in interphase cells.
CUL3 was observed at the centrosome at late G2 or prophase,
started accumulating at the spindle poles in prometaphase, and
stayed on the spindle poles and the mitotic spindle at metaphase
(Fig. 3A). To further confirm our observation from the
immunofluorescence staining, centrosomes were purified from
nocodazole/cytochalasin D-treated U2OS cells by sucrose
gradient ultracentrifugation, and subjected to western blotting
(Fig. 3B). In agreement with the immunofluorescence data,
CUL3 was observed in the centrosomal fraction along with two
other known centrosomal proteins: c-tubulin and TOGp. These
results demonstrate that CUL3 localizes and may function at the
centrosome, mitotic spindle, and the spindle poles.
Identification of KLHL18 as a mitotic BTB protein
To investigate the role of the CUL3 ligase in mitotic entry, we
analyzed the CUL3 complex, especially looking for BTB proteins
which could be potential substrate adaptors of CUL3 E3 ligases
in early mitosis. We utilized cytostatic factor (CSF)-arrested
Xenopus egg extract, which contains all the proteins and
complexes present during mitosis in abundance, making it ideal
for the study of mitosis. Using a Xenopus CUL3 antibody, we
immunoprecipitated CUL3 complexes from the egg extracts. The
CUL3 and control pre-immune serum precipitated complexes
were resolved by SDS-PAGE and stained with Coomassie blue.
The specific protein bands in the CUL3 immunocomplex and
corresponding bands in pre-immune serum precipitated complex
were analyzed by tandem mass-spectrometry and we found two
uncharacterized BTB proteins, KLHL18 and KBTBD2,
exclusively in the CUL3 immunocomplex (supplementary
material Table S1). Since CSF arrests Xenopus embryos at
metaphase, KLHL18 and KBTBD2 are major, if not the only,
CUL3 interacting BTB proteins in early mitosis. Therefore, we
chose these two proteins for further analysis in early mitotic
regulation. We tested mitotic entrance delay in KLHL18 or
KBTBD2 depleted synchronized cells and found KLHL18
depletion caused mitotic entrance delay similar to CUL3
depleted cells (Fig. 4A), but KBTBD2 depleted cells did not
(data not shown).
To ensure that the mitotic delay that we were observing in
CUL3 and KLHL18 knockdown cells was not a consequence of
an earlier defect occurring in S phase, we performed a BrdU
assay to monitor if S phase was progressing and completing
normally in these cells. We BrdU pulsed our synchronized
control, CUL3 and KLHL18 knockdown cells at 1 hour and 6
hours after release, followed by flow cytometry analysis to assess
BrdU incorporation. At both the early and late time points:
control, CUL3 and KLHL18 knockdown cells showed almost the
same pattern of BrdU incorporation, indicating that S phase was
occurring normally in all the cells (Fig. 4B). Additionally to
assess if the reduced mitotic index was due to any DNA damage
being caused earlier, we performed a western blot for phospho-
Chk1 protein, a marker for DNA damage. Control, CUL3 and
KLHL18 knockdown cells showed no signal for the phospho-
Chk1 protein, whereas U2OS cells treated with UV showed a
phospho-Chk1 signal (Fig. 4C). These results illustrate that
CUL3 and KLH18 knockdown cells progress through S phase
normally and do not display any DNA damage.
KLHL18 interacts with CUL3
KLHL18 has a BTB domain at its N-terminus, six kelch repeats
at its C-terminus, and a BTB and C-terminal Kelch (BACK)
domain in between (Fig. 5A). It has been reported that the
Drosophila homolog of human KLHL18 forms a complex with
CUL3 to target GC5808 and GC10324 for ubiquitylation, and is
required for normal thorax development (Fujiyama-Nakamura
et al., 2009). Functions of human KLHL18 in cell cycle control
Fig. 3. CUL3 localizes at centrosomes and the mitotic spindle
(A) U2OS cells were fixed with paraformaldehyde (top panels) or
methanol (bottom panels) and immunostained with indicated
antibodies. DNA was counter-stained by DAPI. Representative
pictures of cells in late G2 phase (Interphase), prophase,
prometaphase, and metaphase are shown. White arrowheads
indicate colocalization of a-tubulin or c-tubulin and CUL3 in
interphase and propahse. Scale bars, 10 mm. (B) Whole cell
extract and purified centrosomes from U2OS cells were subjected
to WB with indicated antibodies.
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are not known. We first determined whether human KLHL18
forms a complex with CUL3 in mitosis. Ectopically expressed
FLAG-tagged KLHL18 interacted with endogenous CUL3 in
nocodazole arrested mitotic HeLa cells (Fig. 5B).The N-terminal
of CUL3 interacts with the BTB domain in a large number of
BTB proteins (Furukawa et al., 2003; Xu et al., 2003). We
determined the residues important for interaction between CUL3
and KLHL18 (Fig. 5C). As expected, the deletion of N-terminus
41 amino acids of CUL3 (CUL3DN41) disrupts interaction with
KLHL18, and the deletion of N-terminus 65 amino acids within
the BTB domain of KLHL18 (KLHL18DBTB) disrupts
interaction with CUL3 (Fig. 5C). These data demonstrate that
the BTB domain in KLHL18 interacts with the N-terminus of
CUL3, similar to known BTB proteins in other CUL3 ligases
(Furukawa et al., 2003; Geyer et al., 2003; Furukawa and Xiong,
2005). We also confirmed endogenous CUL3 and KLHL18
interaction in U2OS cells (Fig. 5D). These findings support that
KLHL18 forms an E3 ligase with CUL3 and the CUL3-KLHL18
ligase may regulate mitotic entry.
The CUL3-KLHL18 ligase is involved in Aurora-A activation at
the centrosome
Next, we investigated how the CUL3-KLHL18 ligase controls
mitotic entry. Since CUL3 or KLHL18 depletion delays mitotic
entry (Fig. 4A) and CUL3 localizes at centrosomes and spindle
poles (Fig. 3), the CUL3-KLHL18 ligase may target a
centrosomal protein that controls mitotic entry. Aurora-A
kinase localizes at the centrosome in interphase and is activated
for initiating mitotic entry (Hirota et al., 2003; Macurek et al.,
2008; Seki et al., 2008). The phosphorylation of Aurora-A kinase
on Thr288, located in the activation T loop of the kinase,
markedly increases its enzymatic activity (Walter et al., 2000).
Knockdown of Aurora-A in human cultured cells results in
mitotic entrance delay that is similar to CUL3 or KLHL18
knockdown (Hirota et al., 2003) (Fig. 4A). To determine the
possibility of CUL3-KLHL18 regulating mitotic entry by
regulation of Aurora-A, we monitored Aurora-A and Thr288
phosphorylated Aurora-A (Aurora-A T288-P) in control, CUL3,
or KLHL18 depleted U2OS cells after release from double
thymidine block, by western blotting. In control cells, both total
Aurora-A and Aurora-A T288-P expression increased in 6 to 8
hours after release from double thymidine block (Fig. 6A),
consistent with previous reports (Hirota et al., 2003; Seki et al.,
2008). In CUL3 or KLHL18 depleted cells, Aurora-A protein
expression also increased in 6 to 8 hours after release, similar to
control cells. However, Aurora-A T288-P expression did not
increase by this time (Fig. 6A), suggesting Aurora-A activation
was delayed in CUL3 or KLHL18 depleted cells. We also
monitored several Aurora-A activators including TPX2, Ajuba,
and Arpc1b but the kinetics of the expression of these proteins
was not significantly different between control, CUL3 or
KLHL18 siRNA transfected cells (Fig. 6A).
To further determine the spatiotemporal regulation of Aurora-
A by the CUL3-KLHL18 ligase, we analyzed localizations of
Fig. 4. CUL3 and KLHL18 knockdown cells
have delayed mitotic entry but progress
through S phase normally (A) U2OS cells were
synchronized and transfected with indicated
siRNAs as shown in Fig. 2A. Cells were fixed
and stained with DAPI at the indicated times after
release. Over 500 cells were analyzed and the
mitotic index was determined, data are
represented as mean 6 SD. (B, C) U2OS cells
were synchronized and transfected as indicated in
Fig. 2A. (B) At the indicated times following
release cells were pulse labeled with 10uM BrdU
for 2 hours and stained with anti-BrdU-FITC and
7-AAD, and analyzed by flow cytometry. The
percentages of incorporated BrdU are indicated.
(C) Lysates from the indicated time points after
release were analyzed by WB with indicated
antibodies. Lysates from U2OS cells treated with
UV were used as a positive control for phospho-
Chk1 blot.
Aurora-A regulation by CUL3-KLHL18 85
B
io
lo
g
y
O
p
e
n
Aurora-A and Aurora-A T288-P at mitotic entry in control,
CUL3 or KLHL18 depleted U2OS cells by immunofluorescence
microscopy. Synchronized and siRNA transfected U2OS cells
were fixed 10 hours after release form double thymidine block,
and Aurora-A T288-P was detected at centrosomes in 90% of
control siRNA transfected prophase cells but only in 13% of
CUL3 siRNA and 40% of KLHL18 siRNA transfected prophase
cells (Fig. 6B,D), suggesting that Aurora-A activation at the
centrosome at mitotic entry is delayed in CUL3 or KLHL18
depleted cells. In the same conditions, Aurora-A localized at
centrosomes in most of control, CUL3, or KLHL18 siRNA
transfected prophase cells (Fig. 6C,E). These results reveal that
the CUL3-KLHL18 ligase is required for activation of Aurora-A
at centrosomes at mitotic entry.
CUL3 and KLHL18 physically interact with Aurora-A
Since CUL3 or KLHL18 depletion results in the delay of Aurora-A
activation at the centrosomes and we observed that CUL3 localized
at the centrosomes, we wanted to determine the possibility that
CUL3-KLHL18 targets Aurora-A for ubiquitylation. For this we
checked if Aurora-A physically interacts with the CUL3-KLHL18
ligase. We immunoprecipitated CUL3 from nocodazole arrested
U2OS cells and found CUL3 specifically interacted with Aurora-A
(Fig. 7A). We also found CUL3 specifically interacted with
Aurora-A in Xenopus as well (Fig. 7B). These results
demonstrated that CUL3 physically interacts with Aurora-A in
early mitosis in human cells, and these interactions are conserved in
Xenopus. Next we examined KLHL18 interaction with Aurora-A.
Ectopically expressed FLAG-tagged KLHL18 and Myc-tagged
Aurora-A interaction was detected reciprocally (Fig. 7C). Also,
endogenous Aurora-A interacted with ectopically expressed
FLAG-tagged KLHL18 in 293T cells (Fig. 7D).The direct
interaction of KLHL18 and Aurora-A was determined in vitro.
Bacterially expressed and purified histidine-tagged Aurora-A and
GST-tagged KLHL18 specifically and directly interacted in vitro
(Fig. 7E). These results demonstrate that the CUL3-KLHL18 ligase
physically interacts with Aurora-A.
CUL3-KLHL18 ligase ubiquitylates Aurora-A
To determine if Aurora-A not only interacts with, but also is a
substrate of the CUL3-KLHL18 ligase, we performed an in vivo
ubiquitylation assay with ectopically expressed CUL3 and
KLHL18. FLAG-tagged Aurora-A and HA-tagged ubiquitin
were transfected to 293T cells with or without CUL3 and
KLHL18, ubiquitylated Aurora-A was then immunoprecipitated
by anti-FLAG antibody, and detected by anti-HA antibody.
Overexpression of CUL3 and KLHL18 caused an increase in
Aurora-A ubiquitylation (Fig. 8A top panels). Although Aurora-
A was ubiquitylated by CUL3-KLHL18, Aurora-A was not
stabilized upon the knockdown of CUL3 or KLHL18 indicating
that Aurora-A ubiquitylation was not leading to degradation
(Fig. 6A). Thus the ubiquitylation of Aurora-A by CUL3-
KLHL18 we were observing was not for targeting Aurora-A to
the proteasome. Aurora-A is ubiquitylated for degradation by the
anaphase promoting complex/Cyclosome (APC/C) at mitotic exit
in an N-terminal A box, and C-terminal D box dependent manner
(Littlepage and Ruderman, 2002; Crane et al., 2004). To examine
Aurora-A ubiquitylation specifically by the CUL3-KLHL18
ligase, and not by APC/C, we constructed a C-terminal D box
deletion mutant of Aurora-A (Aurora-A DD) for in vivo ligase
assays. We confirmed Aurora-A DD interacts with KLHL18 by
transfection and IP-western blot assay (data not shown). Indeed
Aurora-A DD ubiquitylation was also stimulated in the presence
of CUL3 and/or KLHL18 (Fig. 8B). We also noticed that
overexpression of both CUL3 and KLHL18 stimulated mono-
ubiquitylation of Aurora-A as well (Fig. 8A,B). To determine if
the CUL3-KLHL18-ROC1 complex is sufficient for Aurora-A
ubiquitylation, we performed an in vitro ubiquitylation assay with
recombinant Aurora-A as a substrate and an immunoprecipitated
CUL3-KLHL18-ROC1 complex from 293T cells as a source of
E3 ligase (Fig. 8C). Aurora-A was ubiquitylated in vitro when
the recombinant Aurora-A was incubated with the CUL3-
KLHL18-ROC1 E3 complex in addition to HA-tagged
ubiquitin, E1, E2, and ATP (Fig. 8D). This ubiquitylation is
CUL3-KLHL18-ROC1 complex dependent (Fig. 8D). Taken
together, these results suggest that the CUL3-KLHL18 ligase
ubiquitylates Aurora-A, which appears to be important for
Aurora-A activation at the centrosome, and proper mitotic entry.
Discussion
In this study, we provide four lines of evidence indicating that the
CUL3-KLHL18 ligase regulates mitotic entry by directly
targeting Aurora-A for ubiquitylation. First, CUL3 localizes at
the centrosome and forms a complex with KLHL18 in mitosis.
Second, the depletion of CUL3 or KLHL18 caused a delay in
mitotic entry as well as delay in Aurora-A activation at the
centrosome. Third, Aurora-A interacts with the CUL3-KLHL18
ligase through direct interaction with KLHL18. Finally,
overexpression of CUL3 and KLHL18 promotes Aurora-A
ubiquitylation in vivo and the CUL3-KLHL18 ligase can
ubiquitylate Aurora-A in vitro. Our data indicate that the
CUL3-KLHL18 ligase interacts with, and ubiquitylates Aurora-
A prior to the onset of mitosis. This ubiquitylation precedes
Fig. 5. KLHL18 interacts with CUL3. (A) Schematic figure of wild type and
mutant of KLHL18. (B) FLAG-tagged KLHL18 expressing plasmids were
transfected to HeLa cells and treated with 100 ng/mL Nocodazole for 12 hours
before lysis. FLAG KLHL18 and endogenous CUL3 interaction was examined
by immunoprecipitation (IP) and WB with indicated antibodies. (C) Wild type
and mutant KLHL18 and CUL3 expressing plasmids were transfected to HeLa
cells. Interactions were examined by IP-WB analysis with indicated antibodies.
(D) Endogenous CUL3 and KLHL18 interaction in U2OS cells was examined
by IP-WB with indicated antibodies
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Aurora-A activation, which also occurs before mitosis, and is
required for mediating mitotic entry. Thus, CUL3-KLHL18 may
regulate mitotic entry through an Aurora-A pathway.
CUL3 localization at the centrosome and interaction
with KLHL18
We have defined a novel CUL3 based E3 ligase, CUL3-KLHL18.
The temporal specificity of this E3 ligase at the onset of mitosis,
as seen in the CSF arrested egg extract, is indicative of its
importance for the regulation of mitotic entry. We also observed
that CUL3 localizes at spindle poles and mitotic spindle during
mitosis (Fig. 3). Does the CUL3-KLHL18 ligase function after
entering mitosis? Aurora-A localizes at spindle poles and the
mitotic spindle throughout mitosis and organizes mitotic spindle
formation. Depletion or inactivation of Aurora-A causes
chromosome misalignment and mitotic spindle disorganization
(Marumoto et al., 2003; Marumoto et al., 2005; De Luca et al.,
2006).The CUL3-KLHL18 ligase may regulate Aurora-A activity
throughout mitosis. Interestingly, we observed chromosome
misalignment in KLHL18 or CUL3 depleted asynchronous
cells (S. Moghe and M. Furukawa, unpublished observations)
suggesting that the CUL3-KLHL18 ligase also functions during
mitotic spindle organization. Additionally time lapse studies
monitoring the progression of cells throughout mitosis in
KLHL18 knockdown cells will be valuable in addressing the
function of KLHL18 beyond the early mitotic stages. It can be
Fig. 6. The CUL3-KLHL18 ligase is involved in
Aurora-A activation at the centrosomes U2OS cells
were synchronized and transfected with indicated siRNAs
according to the protocol in Fig. 2A. (A) Cells were lysed
at the indicated times after release and examined by WB
with indicated antibodies. (B, C) Cells were fixed at
10 hours after release and immunostained with indicated
antibodies. DNA was counter-stained by DAPI.
Representative pictures of cells in prophase are shown.
White arrowheads indicate colocalization of c-tubulin and
Aurora-A T288-P or c-tubulin and Aurora-A. Scale bars,
10 mm. (D, E) Colocalization of c-tubulin and Aurora-A
T288-P (D) and c-tubulin and Aurora-A (E) in more than
50 of each siRNA transfected prophase cells
were quantified.
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Fig. 7. KLHL18 interacts with Aurora-A directly. (A) U2OS cells treated with 100 ng/mL Nocodazole for 12 hours were lysed and examined by IP-WB with
indicated antibodies. (B) CSF-arrested Xenopus egg extracts were examined by IP-WB analysis with indicated antibodies. Asterisk shows non-specific band. (C)
FLAG-tagged KLHL18 and Myc-tagged Aurora-A (Myc-Aur-A) expressing plasmids were co-transfected to 293T cells and their interactions were determined by IP-
WB analysis with indicated antibodies. (D) FLAG-tagged KLHL18 expressing plasmid was transfected to 293T cells and the FLAG-KLHL18 and endogenous
Aurora-A interaction was determined by IP-WB with indicated antibodies. (E) Bacterially expressed and purified GST fused KLHL18 or GST and 6x Histidine fused
(His-) Aurora-A were incubated in vitro as indicated and their interactions were determined by GST-pull down assay. The input and GST-pull down reactions were
separated by SDS-PAGE, transferred to a nitrocellulose membrane and examined by Ponceau S staining (upper panel). His-Aurora-A was examined by WB with anti-
Aurora-A antibody as well (bottom panel).
Fig. 8. The CUL3-KLHL18 ligase ubiquitylates Aurora-A in vivo and in vitro. (A, B) FLAG-tagged Aurora-A (A) or Myc-tagged Aurora-A deleted C-terminal
D-box (Aur-ADD) (B) were cotransfected with Myc-tagged or FLAG-tagged CUL3, Myc-tagged or FLAG-tagged KLHL18, and HA-tagged Ubiquitin expressing
plasmids to 293T cells as indicated. Twenty four hours after transfection, cells were lysed with a 1% SDS containing lysis buffer and boiled for 15 min. Denatured
lysates were then diluted with 0.5% NP-40 lysis buffer and IP with anti-FLAG (A) or anti-Myc (B) antibody. The washed immunoprecipitates and the total cell lysate
(input) were resolved by SDS-PAGE, followed by WB with indicated antibodies. (C) CUL3-KLHL18-ROC1 complexes were prepared from triply transfected 293T
cells by IP using anti-FLAG antibody and used as the source of E3 ligase. (D) Bacterially expressed and purified His-tagged Aurora-A (His-Aur-A) (Fig. 6E) was
incubated with the KLHL18-CUL3-ROC1 E3 complex (C), E1, E2, HA-tagged ubiquitin (HA-Ub), and ATP. The reactions were immunoprecipitated with anti-HA
antibody and blotted with anti-Aurora-A antibody to examine Aurora-A ubiquitylation.
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expected that such studies may yield similarities to what we and
others have observed in time lapse studies of CUL3 knockdown
cells throughout mitosis (Fig. 1C) (Sumara et al., 2007).
It is also noteworthy that we and others have identified, by
mass spectrometry, CUL3 interaction with the mitotic motor
protein dynein (supplementary material Table S1) (Bennett et al.,
2010) which is associated with the transport of proteins along
spindle microtubules towards minus ends (Kardon and Vale,
2009). It is plausible that CUL3 interaction with dynein may be
responsible for CUL3 transport to and along microtubules and
towards the centrosomes.
Mitotic entry regulated by the CUL3-KLHL18 ligase
through Aurora-A
The importance of CUL3-KLHL18 in mitotic entry is
consistently evident in our data. Furthermore the activity of
Aurora-A affected by CUL3-KLHL18 corresponds to the time of
mitotic entry. Our present study suggests that ubiquitylation of
Aurora-A, by the CUL3-KLHL18 ligase before mitosis, might
serve as a signal for its activation at mitotic entry. Although
Aurora-A is abundant at the centrosome in G2 to M phase
(Fukuda et al., 2005) (Fig. 6), the majority of Aurora-A only
becomes active around the time of prophase. This activation
process is not completely understood, but requires Aurora-A
interaction with the proteins Ajuba (Hirota et al., 2003; Sabino
et al., 2011), HEF1 (Pugacheva and Golemis, 2005), Arpc1b
(Molli et al., 2010), Cep192 (Joukov et al., 2010), and TPX2
(Eyers et al., 2003; Tsai et al., 2003). Aurora-A ubiquitylation
might promote its interactions with these activators and
thus promote Aurora-A activation. Conversely Aurora-A
ubiquitylation may also inhibit the interaction of Aurora-A with
phosphatases, such as PP1, which inhibit Aurora-A activity
(Katayama et al., 2001). Further study is required to elucidate
how Aurora-A ubiquitylation promotes Aurora-A activation at
the centrosome at mitotic entry.
Non-proteosomal function of the CUL3-KLHL18 ligase
It is apparent from our data that the CUL3-KLHL18 ligase
regulates its substrate Aurora-A in a non-proteasomal fashion.
Knockdown of CUL3 or KLHL18 did not cause any significant
stabilization of Aurora-A (Fig. 6A), and over expression of
CUL3 or KLHL18 did not reduce expression of Aurora-A
(Fig. 8), consistent with our interpretation that CUL3-KLHL18
ubiquitylation of Aurora-A does not target Aurora-A for
degradation. Rather, our data indicates that CUL3-KLHL18 has
a novel, proteasome independent function of regulating the
activity of Aurora-A. Non-proteasomal functions of CUL3 based
E3 ligases have been previously reported in metaphase, mitotic
progression and completion of mitosis, for regulating the
localization of the Aurora B kinase (Sumara et al., 2007;
Maerki et al., 2009). Therefore it is most intriguing that entry into
mitosis is also regulated by a CUL3 based E3 ligase; furthermore
the substrate in this case is yet another Aurora kinase. Our study
assigns an additional role of CUL3 ligases in mitosis, and
underscores the importance of CUL3 and BTB proteins in the cell
cycle and mitosis.
Materials and Methods
Plasmids, antibodies, and chemicals
Plasmids expressing CUL3 and ROC1 were described previously (Furukawa et al.,
2003; Furukawa and Xiong, 2005). Full length and N-terminal 65 amino acid
truncated Human KLHL18 (KLHL18 DBTB) expression plasmids were cloned
into pcDNA3-FLAG vector by PCR amplification from the EST clone using
following primers; full length forward, GGATCCAGATGGTGGAGGACG-
GCGCGGAGGAGCTGGAGGATCTGGTGCACTTCTCCGTGTCTGAGTTGC-
CTAGTCGCGGCTACGGCGTCATGGAGGAG; full length reverse, CCGCTC-
GAGTTAGATGGTGAGGAGAGGGATG; DBTB forward, CGGGATCCCTA-
TGTTTACAAATGACATG; DBTB reverse, same as full length reverse. Human
histone H2B-GFP expressing plasmid was obtained from Geoff Wahl (Salk
Institute). The obtained clones were verified by DNA sequencing. Antibodies to
CUL3 (Furukawa et al., 2003), hemagglutinin (HA) (12CA5, Boehringer-
Mannheim), Myc (9E10, NeoMarker), T7 (Novagen), FLAG (M2, Sigma),
KLHL18 (17229-1-AP, Protein Tech Group, Chicago, IL), GAPDH (MAB374,
Chemicon), TOGp (Cassimeris and Morabito, 2004); gift from Cassimeris, L,
Lehigh Univ. PA), a-tubulin (DM1A, Sigma), c-tubulin (GTU-88 and AK-15,
sigma), phospho-Chk1 Ser317 (Cell Signaling), human Aurora-A (610939, BD),
Xenopus Aurora-A (Tsai et al., 2003), Aurora-A T288-P (C39D8, Cell Signaling),
TPX2 (3164C6a, Santa Cruz), Xenopus TPX2 (Tsai et al., 2003), Ajuba (gift from
Keith Johnson, University of Nebraska Medical Center), Arpc1b (IMG-3367,
Imgenex, CA), and actin (C-11; Santa Cruz) were previously described or
purchased commercially. A rabbit polyclonal antibody against Xenopus CUL3
was raised against a synthetic peptide corresponding to the conserved C-terminal
region of Xenopus and human CUL3 (QGESDPERKETRQKVDDDRKHE-
IE). MG132 (Peptides International, Louisville, Ky.), nocodazole (Sigma), 4’,6-
diamidino-2-phenylindole (DAPI, Sigma), cytochalasin B (Sigma), Thymidine
(Sigma) and cycloheximide (Sigma) were purchased commercially.
Cell culture, transfection, and immunoprecipitation
U2OS, HeLa and 293T cells were cultured in Dulbecco’s modified Eagle medium
(DMEM, Gibco) supplemented with 10% fetal bovine serum (FBS, Gibco),
100 unit/ml penicillin (Gibco), and 0.1 mg/ml streptomycin (Gibco) in a 37 C˚
incubator with 5% CO2. Transfections were performed using the Lipofectamine
2000 (Invitrogen) transfection reagent according to the manufacturer’s instructions
(for HeLa and U2OS cells) or using calcium phosphate buffer (for 293T cells). For
UV treated U2OS cell lysates, cells were washed with PBS, dishes were uncovered
and exposed to UV irradiation using the germicidal UV lamp in a tissue culture
hood. Except where indicated, cells were lysed with Nonidet P-40 (NP-40) lysis
buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 50 mM NaF, 0.5% NP-40,
1 mM Na3VO4, 1 mM dithiothreitol [DTT], 1 mM phenylmethylsulfonylfluoride
[PMSF], 25 mg/leupeptin, 25 mg/aprotinin, 150 mg/benzamidine, 10 mg/ trypsin
inhibitor). For examining Aurora-A T288-P, phosphatase inhibitor cocktail
(Cantharidin, Bromotetramisole, and Microcystin LR) and 1 mM EDTA were
added to NP-40 lysis buffer described above. All chemicals were purchased from
Sigma if not specified.
BrdU assay and cell cycle analysis
For Bromodeoxyuridine (BrdU) labeling, cells were incubated for 2h with a final
concentration 10 mM of BrdU, 1h and 6h following release from double thymidine
block as shown in Fig. 2A. Cells were stained for BrdU and DNA using the FITC
BrdU Flow kit (BD Bioscience, San Jose, CA) according to manufacturers’
protocol. Cell cycle analysis was performed by flow cytometry using a BD
FACScalibur (BD Bioscience, San Jose, CA) according to the manufacturers’
instructions. Analysis of the list mode data was performed using Modfit software
(Verity Softwarehouse, Topsham, ME) (Telford et al., 1991).
Isolation of centrosomes
Centrosomes were isolated from U2OS cells by discontinuous gradient
ultracentrifugation as described previously (Mitchison and Kirschner, 1986). In
brief, cells were treated with cytochalasin B (5 mg/ml) and nocodazole (10 mg/ml)
for 90 minutes. After washing, cells were collected with buffer LB (1 mM Tris-Cl,
8 mM beta-mercaptoethanol). After 10 min incubation, Pipes (final 10 mM) and
EDTA (final 1 mM) were added to the cells and cells were spun for 3 min at
3000 rpm at 4 C˚. The supernatant was overlayed onto a Ficoll cushion (20% (w/w)
Ficoll (MW 400,000), 0.1% NP-40, 10 mM Pipes, 1 mM EDTA and spun
12,700 rpm for 15 min. at 4 C˚. The supernatant was aspirated and the interface of
the Ficoll cushion was collected, then overlayed onto discontinuous (62.5% and
20% (w/w)) sucrose gradient in 10 mM PIPES, 1 mM EDTA, 8 mM beta-
mercaptoethanol. The sample was spun for 90 min at 12,700 rpm at 2 C˚. The
sample was fractionated and the fraction between 48 and 60% (w/w) sucrose was
assayed.
RNA interference and cell synchronization
Double-stranded control non-targeting, CUL3 or KLHL18 targeting siRNAs (On-
Target plus, Dharmacon) were transfected to U2OS cells by Lipofectamine RNAi
Max (Invitrogen) transfection reagent according to the manufacturer’s instructions.
The target sequences of the siRNAs were as follows: CUL3-1, 59-
GUCGUAGACAGAGGCGCAA; CUL3-2, 59-GAAGGAAUGUUUAGGGAUA;
KLHL18-1, 59-GGGAUGAGCUGAAUGUCAA; KLHL18-2, 59-GAGAGAUG-
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CCGUCCCAUGA; KLHL18-3, 59-GUGCGUUGCUGCCACAAAU; KLHL18-4,
59-CAGAAGAGAUGGCGAAACG. RNAi experiments in supplementary
material Table S1 and Fig. 1, used individual CUL3 siRNAs. Other experiments
used a pool of two CUL3 siRNAs for CUL3 depletion or a pool of four KLHL18
siRNAs for KLHL18 depletion.
Xenopus egg extract preparation, immunopurification and mass
spectrometric analysis
CSF-arrested Xenopus egg extracts were prepared as described previously (Tsai et
al., 2003). CSF-arrested Xenopus egg extracts (300 ml/IP) was pre-cleaned with
protein A beads for 30 min at 4 C˚ and cleared by centrifugation. The cleared
extract was diluted with 0.1% NP-40 lysis buffer (1:2), then immunoprecipitated
by anti-Xenopus CUL3 antibody (20 mg) or pre-immune serum overnight. The
reaction was cleared by centrifugation then incubated with protein A beads (20 ml/
IP) for 1 hr. CUL3 immunocomplexes were resolved by SDS–PAGE, stained with
Coomassie blue, and the protein bands in the CUL3 IP and corresponding gel
bands in pre-immune IP were excised and subjected to LC/MS at the University of
Nebraska Proteomics Core Facility (Lincoln, NE) as described previously (Kayser
et al., 2004). Briefly, gel pieces were digested by trypsin (no.V5111, Promega,
Madison, WI) and digested peptides were extracted in 5% formic acid / 50%
acetonitrile and separated using C18 reversed phase LC column (75
micron615 cm, BEH 130, 1.7 micron Waters, Milford, MA). A Q-TOF Ultima
tandem mass spectrometer couple with a Nanoaquity HPLC system (Waters) with
electrospray ionization was used to analyze the eluting peptides. The system was
user controlled employing MassLynx software (v 4.1, Waters) in data-dependant
acquisition mode with the following parameters: 0.9-sec survey scan (380–
1900 Da) followed by up to three 1.4-sec MS/MS acquisitions (60–1900 Da). The
instrument was operated at a mass resolution of 8000. The instrument was
calibrated using the fragment ion masses of doubly protonated Glu-fibrinopeptide.
The peak lists of MS/MS data were generated using Distiller (Matrix Science,
London, UK) using charge state recognition and de-isotoping with the other default
parameters for Q-TOF data. Data base searches of the acquired MS/MS spectra
were performed using Mascot (Matrix Science, v2.2.0, London, UK). The NCBI
database (20100701) was used in the searches. Search parameters used were: no
restrictions on protein molecular weight or pI, enzymatic specificity was set to
trypsin with up to 3 missed cleavage sites, carbamidomethylation of C was
selected as a fixed modification, and methionine oxidaztion was selected as a
variable modification. Mass accuracy settings were 0.15 daltons for peptide mass
and 0.12 daltons for fragment ion masses.
Immunofluorescence microscopy
For CUL3 immunofluorescence staining, cells were fixed in 3% paraformaldehyde
for 10 min followed by permeabilization with 0.2% Triton X-100 in PBS for
5 min and blocking with 10% donkey serum in PBS for 1 hour. For Aurora-A or
T288 phosphorylated Aurora-A immunofluorescence staining, cells were fixed
with methanol for 10 min at 220 C˚ followed by permeabilization with 1% triton
X-100 in TBS for 5 min. After permeabilization, cells were incubated with
blocking solution containing 10% donkey serum and 0.1% Triton X-100 in TBS
for 1 hour. After blocking, cells were stained with primary antibodies followed by
incubation with secondary antibody conjugated with Alexa 488 or Alexa 594 for
1 hour. Cells were counterstained with DAPI for DNA. Images were captured
using a 40X oil objective with the Olympus IX81 inverted fluorescence
microscope equipped spinning disc confocal system. For time lapse-
experiments Histone H2B-GFP stably expressing HeLa cells were transfected
with either control or CUL3 siRNAs. 48h after transfection, cells were analyzed
by time-lapse microscopy. An Olympus IX81 inverted fluorescence live
microscope equipped with a spinning disc confocal system and a humidified
CO2 incubator, was used to take snapshots every 5 minutes using an ORCA-ER
camera (Hamamatsu Photonics).
GST fusion protein pull-down assay
Full-length human KLHL18 and Aurora-A cDNA were cloned into pGEX and
pET-His vectors, respectively. The six-histidine (His6)-tagged fusion proteins
were purified with Ni-nitrilotriacetic acid(NTA) agarose (QIAGEN) after
induction with 0.4 mM isopropyl-1-ß-D-galactopyranoside (IPTG, Sigma) for
4 h in exponentially growing Escherichia coli BL21(DE3) cells cultured at 30 C˚.
GST or GST fusion proteins were purified with glutathione agarose (Sigma) after
induction with 0.4 mM IPTG for 4 h in exponentially growing E. coli XL1-Blue
cells cultured at 30 C˚. One microgram of purified His6-tagged fusion proteins
were incubated with 1 mg of purified GST or GST-KLHL18 fusion proteins
immobilized on the glutathione agarose in buffer A, which contains 50 mM Tris-
HCl (pH 7.5), 1 mM EDTA, 120 mM NaCl, 10% glycerol, 0.5% NP-40, 1 mM
DTT, 0.5 mM PMSF, and 1 mg of bovine serum albumin. After 1 h incubation
at room temperature, the glutathione agarose beads were washed with buffer A
three times and resolved by SDS-PAGE, followed by Ponceau S staining or WB
with anti-Aurora-A antibody.
Ubiquitin ligase activity assay
The procedures for the in vivo and in vitro ubiquitin ligase activity assays were
performed as previously described (Furukawa et al., 2003; Furukawa et al., 2005;
Furukawa and Xiong, 2005). Briefly, for in vivo ubiquitylation assays, Myc-tagged
Aurora-A DD, FLAG-tagged CUL3, FLAG-tagged KLHL18, and HA-tagged
Ubiquitin expressing plasmids were transfected to 293T cells as indicated. Twenty
four hours after transfection, cells were lysed with a 1% SDS lysis buffer
(50 mMTris-HCl, pH 7.5, 0.5 mM EDTA, 1% SDS, 1 mM DTT) and boiled for
15 min to dissociate any protein-protein interaction except ubiquitylation. Lysates
were then diluted ten times with 0.5% NP-40 lysis buffer and immunoprecipitated
with anti-Myc antibody. The washed immunoprecipitates were resolved by SDS-
PAGE, followed by WB with anti-HA antibody to examine ubiquitylated Aurora-
A. For in vitro ubiquitin ligase assays, 293T cells were cotransfected with plasmids
expressing Myc-tagged CUL3, FLAG-tagged KLHL18, and Myc-tagged ROC1.
Twenty-four hours after transfection, cells were lysed and immunoprecipitated
with an anti-FLAG antibody. FLAG-KLHL18 immunocomplexes immobilized on
anti-FLAG antibody conjugated-agarose beads were incubated with 1 mg of
purified His-tagged Aurora-A in a ubiquitin ligation reaction mixture (final
volume, 30 ml) containing 50 mM Tris-HCl (pH 7.4), 5 mM MgCl2, 2 mM NaF,
10 nM okadaic acid, 2 mM ATP, 0.6 mM DTT, 1 mg of HA-tagged ubiquitin
(Furukawa et al., 2002), 60 ng of E1 (Boston Biochem), and 300 ng of E2-UbcH5c
(Furukawa et al., 2002) at 37 C˚ for 1 h. The reaction was terminated by boiling for
15 min in a 1% SDS lysis buffer then diluted ten times with 0.5% NP-40 lysis
buffer and IP with anti-Myc antibody. The washed immunoprecipitates were
resolved by SDS-PAGE, followed by WB with anti-HA antibody to examine
ubiquitylated Aurora-A.
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